CClinicalTrials.gg
Enrolling by invitationNCT07504614Updated Aug 11, 2026

Pre-etched Bioactive Versus Resin- Based Fissure Sealant for Permanent Molars Affected With Molar Incisor Hypomineralization (MIH).

An interventional study of Pre-etched Bioactive Sealant and Conventional Resin-based Sealant in Molar Incisor Hypomineralization and Fissure Sealant, sponsored by Jordan University of Science and Technology. Enrolling by invitation at 1 site in Jordan. Open to participants aged 6 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-11.

Sponsored by Jordan University of Science and Technology · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
6 Years to 12 Years
Sex
All
01

Study summary

This study aims to evaluate and compare the clinical performance of pre-etched bioactive fissure sealants to conventional RBFS in permanent molars affected by MIH in terms of retention, marginal integrity, caries prevention effect, and sensitivity.

Read the detailed description

Molar Incisor Hypomineralization (MIH) poses a significant clinical challenge in pediatric dentistry due to enamel fragility, hypersensitivity, and increased susceptibility to caries. While conventional resin-based fissure sealant (RBFS) is the gold standard fissure sealant material for occlusal caries, its performance on hypomineralized enamel remains suboptimal. Bioactive sealants are newly developed materials that promote remineralization and utilize both mechanical and chemical adhesion; however, they demonstrate poor retention when used with their self-etching primer. Bioactive sealants with phosphoric acid pre-etching may offer improved clinical outcomes for MIH-affected teeth. This study aims to evaluate and compare the clinical performance of pre-etched bioactive fissure sealants to conventional RBFS in permanent molars affected by MIH in terms of retention, marginal integrity, caries prevention effect, and sensitivity. Participants will be randomly allocated to receive either a bioactive sealant with phosphoric acid pre-etching or conventional RBFS. Clinical evaluations will be performed at 3-, 6-, and 12- months post-application using Modified United States Public Health Service (USPHS) criteria to assess retention, marginal adaptation, and secondary caries formation. Pre and postoperative sensitivity will be measured using the Schiff Cold Air Sensitivity Scale (SCASS).

02

Conditions studied

  • Molar Incisor Hypomineralization
  • Fissure Sealant

Keywords

  • Molar Incisor Hypomineralization
  • Fissure sealant
  • Children
  • Bioactive Dental material
03

Who can participate

Ages eligible
6 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • 6-12-year-old patients with at least one fully erupted first permanent molar (FPM) diagnosed with MIH defects (White, creamy, or yellow to brownish opacities greater than one millimetre) without posteruptive enamel breakdown or caries (ICDAS code 0 or 1).
  • Non -contributory medical history
  • Children must exhibit sufficient cooperation for treatment.
  • FPMs status of eruption must allow for proper isolation. Exclusion Criteria:-
  • Medically compromised patient.- Partially erupted MIH first permanent molars that could not be sufficiently isolated.
  • Carious molars.
  • Restored MIH molars.
  • Sealed MIH molars.
  • MIH molars with extensive enamel breakdown that requires restoration.
  • MIH molars planned for extraction (compensatory or balancing extraction) as part of elective extraction plan of MIH molars with poor long-term prognosis.
  • Molars affected with other enamel defects ((e.g., amelogenesis imperfecta or fluorosis)
  • Non-MIH affected molars.
  • Parents did not consent for treatment.
  • Child not sufficiently cooperative for treatment.
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
76 participants (estimated)

Study arms

  • Experimental
    Pre-etched Bioactive Sealant

    Bioactive fissure sealant applied after etching with phosphoric acid

    Procedure: Pre-etched Bioactive Sealant

  • Active comparator
    Resin-based fissure sealant

    Resin-based fissure sealant is applied after etching with phosphoric acid

    Procedure: Conventional Resin-based Sealant

Interventions

  • ProcedurePre-etched Bioactive Sealant

    Application of the bioactive sealant after etching, washing, drying, and primer use.

  • ProcedureConventional Resin-based Sealant

    Application of resin-based fissure sealant after etching, washing, drying and bonding.

05

What researchers measure

Primary outcomes

  1. Sealant retention

    Evaluation of sealant retention using the Modified United States Public Health Service (USPHS) criteria under good light source and using a dental mirror and a straight explorer

    Time frame: 3,6 and 12 months

  2. Marginal integrity

    Evaluation for the presence of fractures or gaps in the sealant-tooth interface using the Modified United States Public Health Service (USPHS) criteria under a good light source and using a dental mirror and straight explorer.

    Time frame: 3,6 and 12 months

  3. Marginal discoloration

    Evaluation for marginal discolouration using the Modified United States Public Health Service (USPHS) criteria under good light source and using a dental mirror

    Time frame: 3,6 and 12 months

  4. Secondary Caries

    Evaluation for new caries using the Modified United States Public Health Service (USPHS) criteria under a good light source and using a dental mirror and a straight explorer.

    Time frame: 3,6 and 12 months

  5. Anatomic form

    Evaluation of anatomic form using the modified United States of Public Health Service Criteria.

    Time frame: 3,6 and 12 months

  6. Surface Texture

    Evaluation for surface texture using the modified United States of Public Health Service Criteria

    Time frame: 3,6 and 12 months

Secondary outcomes

  1. Sensitivity

    Evaluation of pre-operative and post-operative sensitivity using the Schiff Cold Air Sensitivity Scale (SCASS).

    Time frame: Pre-operative, 3,6, and 12 months

06

Study locations

1 site
  • Jordan University of Science and Technology
    Irbid, Jordan
07

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07504614
Lead sponsor
Jordan University of Science and Technology
Responsible party
Sponsor
First posted
Apr 1, 2026
Start date
Aug 1, 2025
Primary completion
Aug 30, 2027 (estimated)
Completion
Aug 30, 2027 (estimated)
Last update
Aug 11, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion